Sihuan Pharmaceutical Holdings Group Ltd. (460) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.

Zhongzhi Pharmaceutical Holdings Ltd.

China Shineway Pharmaceutical Group Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

CK Life Sciences International (Holdings), Inc.

HBM Holdings Ltd.

Sihuan Pharmaceutical Holdings Group Ltd.

Wai Yuen Tong Medicine Holdings Ltd.

PuraPharm Corp. Ltd.

Hin Sang Group (International) Holding Co. Ltd.

China Health Group, Inc.

Why is Sihuan Pharmaceutical Holdings Group Ltd. ?

Weak Long Term Fundamental Strength with a -193.65% CAGR growth in Operating Profits over the last 5 years

High Debt Company with a Debt to Equity ratio (avg) at times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 113.64%, its profits have fallen by -20.7%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sihuan Pharmaceutical Holdings Group Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Sihuan Pharmaceutical Holdings Group Ltd.

113.64%

3.06

56.00%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.18%

EBIT Growth (5y)

-193.65%

EBIT to Interest (avg)

7.73

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.67

Sales to Capital Employed (avg)

0.33

Tax Ratio

10.46%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

3.59%

ROE (avg)

1.99%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.93

EV to EBIT

-23.79

EV to EBITDA

-60.16

EV to Capital Employed

6.77

EV to Sales

5.11

PEG Ratio

Dividend Yield

0.68%

ROCE (Latest)

-28.46%

ROE (Latest)

-11.07%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Sideways

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company

INVENTORY TURNOVER RATIO(HY)

Highest at 1.15 times

DIVIDEND PAYOUT RATIO(Y)

Highest at 90.83%

NET SALES(Q)

Highest at HKD 1,231.2 MM

OPERATING PROFIT(Q)

Highest at HKD 285.31 MM

OPERATING PROFIT MARGIN(Q)

Highest at 23.17 %

PRE-TAX PROFIT(Q)

Highest at HKD 170.32 MM

NET PROFIT(Q)

Highest at HKD 109.82 MM

EPS(Q)

Highest at HKD 0.01

-5What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at HKD 591.86 MM

RAW MATERIAL COST(Y)

Grown by 6.82% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -64.54 %

Here's what is working for Sihuan Pharmaceutical Holdings Group Ltd.

Pre-Tax Profit

At HKD 170.32 MM has Grown at 650.94%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Net Profit

At HKD 109.82 MM has Grown at 362.57%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (HKD MM)

Inventory Turnover Ratio

Highest at 1.15 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Sales

Highest at HKD 1,231.2 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Operating Profit

Highest at HKD 285.31 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Operating Profit Margin

Highest at 23.17 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at HKD 170.32 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit

Highest at HKD 109.82 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS

Highest at HKD 0.01

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Dividend Payout Ratio

Highest at 90.83%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Here's what is not working for Sihuan Pharmaceutical Holdings Group Ltd.

Operating Cash Flow

Lowest at HKD 591.86 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Debt-Equity Ratio

Highest at -64.54 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 6.82% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales